Skip to main content

Cancer Genomics at ICHG

Premium

Researchers at the International Congress of Human Genetics meeting in Montreal, Quebec, gave an update this morning on the status of some International Cancer Genome Consortium projects, particularly those on pancreatic, oral, and stomach cancer. New sequencing technologies have spurred the ICGC to sequence about 500 tumor varieties to try to find genomic, epigenomic, and transcriptomic changes that occur in those cancers. "It is relatively simple to think about doing cancer genomics," said session chair Tom Hudson from the Ontario Institute for Cancer Research. There are now 17,000 consenting donors for ICGC projects, and data from about 2,000 of those maybe found on the consortium's Web site.

Two speakers during the session touched on difficulties facing researchers in sequencing pancreatic cancer samples. One problem is that pancreatic tumor samples often include a fair amount of normal tissue, due to the characteristics of the tumor. However, the Broad Institute's Stacey Gabriel and her colleagues at The Cancer Genome Atlas showed that deep sequencing of such mixed samples could pick up pancreatic cancer mutations. Alternatively, John McPherson at OICR has used different enrichment approaches to increase the amount of usable tumor, also with some success.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.